Showing results (1-10 of 1,080) with videos related to
Sort By:
Pageof 108
The Journal of Urology|June 11, 2005
Update on chemotherapy for advanced bladder cancerJonathan E Rosenberg, Peter R Carroll, Eric J SmallClinical Prostate Cancer|October 14, 2004
Second-line chemotherapy for hormone-refractory prostate cancer: has the time come?Jonathan E Rosenberg, Eric J SmallSeminars in Urologic Oncology|August 29, 2002
Neoadjuvant strategies for prostate cancer prior to radical prostatectomyMaxwell V Meng, Gary D Grossfeld, Peter R Carroll, et al.BJU International|April 5, 2007
Evaluation and significance of circulating epithelial cells in patients with hormone-refractory prostate cancerJorge A Garcia, Jonathan E Rosenberg, Vivian Weinberg, et al.Clinical Prostate Cancer|May 11, 2005
Lifestyle correlates of health perception and treatment satisfaction in a clinical cohort of men with prostate cancerSara K Sheriff, Ryo A Shohara, Sarah B Dumican, et al.Cancer|December 6, 2005
A retrospective evaluation of second-line chemotherapy response in hormone-refractory prostate carcinoma: second line taxane-based therapy after first-line epothilone-B analog ixabepilone (BMS-247550) therapyJonathan E Rosenberg, Matthew D Galsky, Nicholas C Rohs, et al.BJU International|June 27, 2006
A phase II trial of imatinib mesylate in patients with biochemical relapse of prostate cancer after definitive local therapyAmy M Lin, Brian I Rini, Vivian Weinberg, et al.Cancer Cell|July 12, 2017
Redefining Hormonal Therapy for Advanced Prostate Cancer: Results from the LATITUDE and STAMPEDE StudiesEric J SmallCancer|June 20, 2007
Activity of second-line chemotherapy in docetaxel-refractory hormone-refractory prostate cancer patients : randomized phase 2 study of ixabepilone or mitoxantrone and prednisoneJonathan E Rosenberg, Vivian K Weinberg, W Kevin Kelly, et al.Expert Review of Anticancer Therapy|December 8, 2007
Current status of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancerJonathan E RosenbergPageof 108